Novacyt: David Allmond, Graham Mullis

Clinical diagnostics company Novacyt announced the appointment of David Allmond as CEO and a member of its board of directors, effective Oct. 18.

Allmond is chief business officer at Amryt Pharma, a rare and orphan disease drug company. He previously held sales and marketing roles at Amgen, Celgene, and Aegerion Pharmaceuticals.

Graham Mullis is retiring and will stand down as the company's CEO and board member.